Evidence map›Paper›PMID 41107374›Full record

ArticleScientific reports2025

Risk assessment of pARDS in severe pneumonia patients based on lung injury prediction scores and serum biomarkers.

Junying Qiao, Yuhui Feng, Chenhang Cui, Lanlan Zou, Xianjie Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Junying QiaoDepartment of Pediatric Critical Care Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China. junying.qiao@163.com.
Yuhui FengDepartment of Pediatric Critical Care Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chenhang CuiDepartment of Pediatric Critical Care Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lanlan ZouDepartment of Pediatric Critical Care Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xianjie HuangDepartment of Pediatric Critical Care Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to evaluate the predictive value of the Lung Injury Prediction Score (LIPS) combined with serum markers including Krebs von den Lungen-6 (KL-6), surfactant protein D (SP-D), von Willebrand factor (vWF), and interleukin-8 (IL-8) in predicting pediatric acute respiratory distress syndrome (pARDS) in critically ill children with severe pneumonia in the PICU. This study enrolled 97 children with severe pneumonia admitted to the PICU. They were classified into the pARDS group or non-pARDS group based on whether pARDS developed within 7 days of admission. LIPS and serum levels of KL-6, SP-D, vWF, and IL-8 were recorded and measured at PICU admission (T

Indexed as

BiomarkersLung InjuryPneumoniaRespiratory Distress SyndromeChildChild, PreschoolFemaleHumansInfantIntensive Care Units, PediatricInterleukin-8MaleMucin-1Pulmonary Surfactant-Associated Protein DRisk AssessmentROC CurveBiomarkersInterleukin-8MUC1 protein, humanMucin-1Pulmonary Surfactant-Associated Protein Dvon Willebrand FactorKrebs von den lungen-6Lung injury prediction scorePediatric acute respiratory distress syndromeSurfactant protein dVon willebrand factor

Identifiers

PMID41107374
PMCPMC12534437

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.